Clinical Trial Update: Effect of Prasugrel Versus Clopidogrel on Platelet Function After Bivalirudin Cessation [Phase 4]

View source ↗

Summary

This Phase 4 trial compares prasugrel versus clopidogrel on platelet function after stopping bivalirudin in patients with coronary artery disease, with results …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• CLOPIDOGREL (CLOPIDOGREL)
• PRASUGREL (prasugrel)

Snippet

Sponsor: Tufts Medical Center | Conditions: Coronary Artery Disease | Phase 4 | Status: COMPLETED | Results posted: 2017-04-04